Asbury United Methodist Church
Sharing Christ's Love Generation to Generation

Food and Medication Administration for the brand new drug program for AXANUM tablets.

AstraZeneca Receives FDA Complete Response Letter for AXANUM New Medication Application AstraZeneca has received a Complete Response Letter from the U.S. Food and Medication Administration for the brand new drug program for AXANUM tablets. The business also received a CRL for the supplemental brand-new drug program for NEXIUM . AstraZeneca is analyzing the CRLs currently, and can continue discussions with the FDA to find out next steps regarding both AXANUM NDA along with the NEXIUM sNDA and can react to the agency’s obtain additional information.The ongoing organization is in an activity of finalizing the search of an established, international independent registered public accounting firm and will make a timely announcement when the search can be total and the engagement of a successor independent authorized public accounting company becomes effective.

Aushon BioSystems introduces new Individual multiplex biomarker panels Aushon BioSystems, Inc., a respected company of advanced microarray laboratory and instrumentation providers for biomarker discovery, analysis and development, has released new Human being multiplex biomarker panels for the quantification of eight biomarkers linked to drug-induced kidney harm, or nephrotoxicity.